 | • レポートコード：QYR9ST03205 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、感染症の世界市場について調査・分析し、感染症の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（抗菌薬、抗ウイルス薬、抗真菌薬、駆虫薬）、用途別（後天性免疫不全症候群、B型肝炎、C型肝炎、ヒトパピローマウイルス、病院後天性メチシリン耐性黄色ブドウ球菌感染症、トラコーマクラミジア及び淋菌）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の感染症市場動向 ・主要企業別マーケットシェア ・感染症の種類別市場規模2014-2019 （抗菌薬、抗ウイルス薬、抗真菌薬、駆虫薬） ・感染症の用途別市場規模2014-2019 （後天性免疫不全症候群、B型肝炎、C型肝炎、ヒトパピローマウイルス、病院後天性メチシリン耐性黄色ブドウ球菌感染症、トラコーマクラミジア及び淋菌） ・感染症の北米市場：主要企業・種類別/用途別市場規模 ・感染症のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・感染症の中国市場：主要企業・種類別/用途別市場規模 ・感染症の日本国内市場：主要企業・種類別/用途別市場規模 ・感染症の東南アジア市場：主要企業・種類別/用途別市場規模 ・感染症のインド市場：主要企業・種類別/用途別市場規模 ・感染症の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （F. Hoffmann-La Roche、Gilead Sciences、GlaxoSmithKline、Johnson & Johnson、Merck、Pfizer、AbbVie、Astellas Pharma、AstraZeneca、Bayer、Bristol-Myers Squibb、Chimerix Pharmaceuticals、Cubist、Eli Lilly、Isis Pharmaceuticals、Mitsubishi Tanabe Pharma、Novartis、Sanofi、Vertex ） ・感染症の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents.Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic.
In 2018, the global Infectious Diseases market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Infectious Diseases status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Infectious Diseases development in United States, Europe and China.
The key players covered in this study
F. Hoffmann-La Roche
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Pfizer
AbbVie
Astellas Pharma
AstraZeneca
Bayer
Bristol-Myers Squibb
Chimerix Pharmaceuticals
Cubist
Eli Lilly
Isis Pharmaceuticals
Mitsubishi Tanabe Pharma
Novartis
Sanofi
Vertex
Market segment by Type, the product can be split into
Antibacterial drugs
Antiviral drugs
Antifungal drugs
Antiparasitic drugs
Market segment by Application, split into
Acquired Immune Deficiency Syndrome
Hepatitis B
Hepatitis C
Human Papillomavirus
Hospital acquired Methicillin-resistant Staphylococcus aureus infection
Chlamydia trachomatis and Neisseria Gonorrhea
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Infectious Diseases status, future forecast, growth opportunity, key market and key players.
To present the Infectious Diseases development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Infectious Diseases are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Infectious Diseases Market Size Growth Rate by Type (2014-2025)
1.4.2 Antibacterial drugs
1.4.3 Antiviral drugs
1.4.4 Antifungal drugs
1.4.5 Antiparasitic drugs
1.5 Market by Application
1.5.1 Global Infectious Diseases Market Share by Application (2014-2025)
1.5.2 Acquired Immune Deficiency Syndrome
1.5.3 Hepatitis B
1.5.4 Hepatitis C
1.5.5 Human Papillomavirus
1.5.6 Hospital acquired Methicillin-resistant Staphylococcus aureus infection
1.5.7 Chlamydia trachomatis and Neisseria Gonorrhea
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Infectious Diseases Market Size
2.2 Infectious Diseases Growth Trends by Regions
2.2.1 Infectious Diseases Market Size by Regions (2014-2025)
2.2.2 Infectious Diseases Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Infectious Diseases Market Size by Manufacturers
3.1.1 Global Infectious Diseases Revenue by Manufacturers (2014-2019)
3.1.2 Global Infectious Diseases Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.2 Infectious Diseases Key Players Head office and Area Served
3.3 Key Players Infectious Diseases Product/Solution/Service
3.4 Date of Enter into Infectious Diseases Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Infectious Diseases Market Size by Type (2014-2019)
4.2 Global Infectious Diseases Market Size by Application (2014-2019)
5 United States
5.1 United States Infectious Diseases Market Size (2014-2019)
5.2 Infectious Diseases Key Players in United States
5.3 United States Infectious Diseases Market Size by Type
5.4 United States Infectious Diseases Market Size by Application
6 Europe
6.1 Europe Infectious Diseases Market Size (2014-2019)
6.2 Infectious Diseases Key Players in Europe
6.3 Europe Infectious Diseases Market Size by Type
6.4 Europe Infectious Diseases Market Size by Application
7 China
7.1 China Infectious Diseases Market Size (2014-2019)
7.2 Infectious Diseases Key Players in China
7.3 China Infectious Diseases Market Size by Type
7.4 China Infectious Diseases Market Size by Application
8 Japan
8.1 Japan Infectious Diseases Market Size (2014-2019)
8.2 Infectious Diseases Key Players in Japan
8.3 Japan Infectious Diseases Market Size by Type
8.4 Japan Infectious Diseases Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Infectious Diseases Market Size (2014-2019)
9.2 Infectious Diseases Key Players in Southeast Asia
9.3 Southeast Asia Infectious Diseases Market Size by Type
9.4 Southeast Asia Infectious Diseases Market Size by Application
10 India
10.1 India Infectious Diseases Market Size (2014-2019)
10.2 Infectious Diseases Key Players in India
10.3 India Infectious Diseases Market Size by Type
10.4 India Infectious Diseases Market Size by Application
11 Central & South America
11.1 Central & South America Infectious Diseases Market Size (2014-2019)
11.2 Infectious Diseases Key Players in Central & South America
11.3 Central & South America Infectious Diseases Market Size by Type
11.4 Central & South America Infectious Diseases Market Size by Application
12 International Players Profiles
12.1 F. Hoffmann-La Roche
12.1.1 F. Hoffmann-La Roche Company Details
12.1.2 Company Description and Business Overview
12.1.3 Infectious Diseases Introduction
12.1.4 F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2014-2019)
12.1.5 F. Hoffmann-La Roche Recent Development
12.2 Gilead Sciences
12.2.1 Gilead Sciences Company Details
12.2.2 Company Description and Business Overview
12.2.3 Infectious Diseases Introduction
12.2.4 Gilead Sciences Revenue in Infectious Diseases Business (2014-2019)
12.2.5 Gilead Sciences Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Infectious Diseases Introduction
12.3.4 GlaxoSmithKline Revenue in Infectious Diseases Business (2014-2019)
12.3.5 GlaxoSmithKline Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Infectious Diseases Introduction
12.4.4 Johnson & Johnson Revenue in Infectious Diseases Business (2014-2019)
12.4.5 Johnson & Johnson Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Infectious Diseases Introduction
12.5.4 Merck Revenue in Infectious Diseases Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Infectious Diseases Introduction
12.6.4 Pfizer Revenue in Infectious Diseases Business (2014-2019)
12.6.5 Pfizer Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Infectious Diseases Introduction
12.7.4 AbbVie Revenue in Infectious Diseases Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Astellas Pharma
12.8.1 Astellas Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Infectious Diseases Introduction
12.8.4 Astellas Pharma Revenue in Infectious Diseases Business (2014-2019)
12.8.5 Astellas Pharma Recent Development
12.9 AstraZeneca
12.9.1 AstraZeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Infectious Diseases Introduction
12.9.4 AstraZeneca Revenue in Infectious Diseases Business (2014-2019)
12.9.5 AstraZeneca Recent Development
12.10 Bayer
12.10.1 Bayer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Infectious Diseases Introduction
12.10.4 Bayer Revenue in Infectious Diseases Business (2014-2019)
12.10.5 Bayer Recent Development
12.11 Bristol-Myers Squibb
12.12 Chimerix Pharmaceuticals
12.13 Cubist
12.14 Eli Lilly
12.15 Isis Pharmaceuticals
12.16 Mitsubishi Tanabe Pharma
12.17 Novartis
12.18 Sanofi
12.19 Vertex
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Infectious Diseases Key Market Segments
Table Key Players Infectious Diseases Covered
Table Global Infectious Diseases Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Infectious Diseases Market Size Market Share by Type 2014-2025
Figure Antibacterial drugs Figures
Table Key Players of Antibacterial drugs
Figure Antiviral drugs Figures
Table Key Players of Antiviral drugs
Figure Antifungal drugs Figures
Table Key Players of Antifungal drugs
Figure Antiparasitic drugs Figures
Table Key Players of Antiparasitic drugs
Table Global Infectious Diseases Market Size Growth by Application 2014-2025 (Million US$)
Figure Acquired Immune Deficiency Syndrome Case Studies
Figure Hepatitis B Case Studies
Figure Hepatitis C Case Studies
Figure Human Papillomavirus Case Studies
Figure Hospital acquired Methicillin-resistant Staphylococcus aureus infection Case Studies
Figure Chlamydia trachomatis and Neisseria Gonorrhea Case Studies
Figure Infectious Diseases Report Years Considered
Table Global Infectious Diseases Market Size 2014-2025 (Million US$)
Figure Global Infectious Diseases Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Infectious Diseases Market Size by Regions 2014-2025 (Million US$)
Table Global Infectious Diseases Market Size by Regions 2014-2019 (Million US$)
Table Global Infectious Diseases Market Share by Regions 2014-2019
Figure Global Infectious Diseases Market Share by Regions 2014-2019
Figure Global Infectious Diseases Market Share by Regions 2019
Table Market Top Trends
Table Global Infectious Diseases Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Infectious Diseases Market Share by Manufacturers (2014-2019)
Figure Global Infectious Diseases Market Share by Manufacturers in 2018
Table Global Infectious Diseases Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Infectious Diseases Product/Solution/Service
Table Date of Enter into Infectious Diseases Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table Global Infectious Diseases Market Size Share by Type (2014-2019)
Figure Global Infectious Diseases Market Size Market Share by Type (2014-2019)
Table Global Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table Global Infectious Diseases Market Size Share by Application (2014-2019)
Figure Global Infectious Diseases Market Size Market Share by Application (2014-2019)
Figure Global Infectious Diseases Revenue Market Share by Application in 2018
Figure United States Infectious Diseases Market Size 2014-2019 (Million US$)
Table United States Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table United States Key Players Infectious Diseases Market Share (2018-2019)
Table United States Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table United States Infectious Diseases Market Share by Type (2014-2019)
Table United States Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table United States Infectious Diseases Market Share by Application (2014-2019)
Figure Europe Infectious Diseases Market Size 2014-2019 (Million US$)
Table Europe Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table Europe Key Players Infectious Diseases Market Share (2018-2019)
Table Europe Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table Europe Infectious Diseases Market Share by Type (2014-2019)
Table Europe Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table Europe Infectious Diseases Market Share by Application (2014-2019)
Figure China Infectious Diseases Market Size 2014-2019 (Million US$)
Table China Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table China Key Players Infectious Diseases Market Share (2018-2019)
Table China Infectious Diseases Market Size by Type (2014-20189) (Million US$)
Table China Infectious Diseases Market Share by Type (2014-2019)
Table China Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table China Infectious Diseases Market Share by Application (2014-2019)
Figure Japan Infectious Diseases Market Size 2014-2019 (Million US$)
Table Japan Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table Japan Key Players Infectious Diseases Market Share (2018-2019)
Table Japan Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table Japan Infectious Diseases Market Share by Type (2014-2019)
Table Japan Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table Japan Infectious Diseases Market Share by Application (2014-2019)
Figure Southeast Asia Infectious Diseases Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Infectious Diseases Market Share (2018-2019)
Table Southeast Asia Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Infectious Diseases Market Share by Type (2014-2019)
Table Southeast Asia Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Infectious Diseases Market Share by Application (2014-2019)
Figure India Infectious Diseases Market Size 2014-2019 (Million US$)
Table India Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table India Key Players Infectious Diseases Market Share (2018-2019)
Table India Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table India Infectious Diseases Market Share by Type (2014-2019)
Table India Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table India Infectious Diseases Market Share by Application (2014-2019)
Figure Central & South America Infectious Diseases Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Infectious Diseases Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Infectious Diseases Market Share (2018-2019)
Table Central & South America Infectious Diseases Market Size by Type (2014-2019) (Million US$)
Table Central & South America Infectious Diseases Market Share by Type (2014-2019)
Table Central & South America Infectious Diseases Market Size by Application (2014-2019) (Million US$)
Table Central & South America Infectious Diseases Market Share by Application (2014-2019)
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Infectious Diseases Business (2014-2019) (Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Gilead Sciences Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Merck Company Details
Table Merck Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Pfizer Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table AbbVie Recent Development
Table Astellas Pharma Company Details
Table Astellas Pharma Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Astellas Pharma Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Astellas Pharma Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table AstraZeneca Recent Development
Table Bayer Company Details
Table Bayer Revenue in Infectious Diseases Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Infectious Diseases Business (2014-2019)
Table Bayer Recent Development
Table Bristol-Myers Squibb Company Details
Table Chimerix Pharmaceuticals Company Details
Table Cubist Company Details
Table Eli Lilly Company Details
Table Isis Pharmaceuticals Company Details
Table Mitsubishi Tanabe Pharma Company Details
Table Novartis Company Details
Table Sanofi Company Details
Table Vertex Company Details
Table Global Infectious Diseases Market Size by Regions (Million US$) 2019-2025
Figure Global Infectious Diseases Market Size Share by Regions (2019-2025)
Figure Global Infectious Diseases Market Size Share by Regions in 2025
Figure United States Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Europe Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure China Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Japan Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure India Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Infectious Diseases Market Size Forecast (2019-2025)(Million USD)
Table Global Infectious Diseases Market Size by Product (2019-2025) (Million US$)
Figure Global Infectious Diseases Market Size by Product (2019-2025)
Figure Global Infectious Diseases Market Size by Product in 2025
Table Global Infectious Diseases Market Size by Application (2019-2025) (Million US$)
Figure Global Infectious Diseases Market Size by Application (2019-2025)
Figure Global Infectious Diseases Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
免疫療法薬の世界市場：市場規模・現状・予測 Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.North America is expected to account for largest share in the i…- 抗菌薬の世界市場：インサイト・予測 Antibacterial drugs refer to the substances that can destroy or inhibit the growth of microorganism such as bacteria. Antibacterial drugs are often termed as antibiotics, and widely used in prevention and treatment of infectious dieses. Various classes of these drugs have been developed, according t…
- 短腸症候群（SBS）治療薬の世界市場：市場規模・現状・予測 Short bowel syndrome (SBS) is a metabolic disorder occurs when the portion of the small intestine is not functioning or removed through surgery due to digestive illness. SBS is caused by lack of function of the small intestine. This results in malabsorption, diarrhea, steatorrhea, fluid and electrol…
- 感染症治療の世界市場：市場規模・現状・予測 Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients.In 2018, the global Infectious Disease Treatment market size was xx …
- ヒトマイクロバイオームベース薬物及び診断の世界市場：市場規模・現状・予測 The modern approach involves exploiting the interaction between humans and the bacteria that live in or on the body to develop new drugs and therapies to treat chronic diseases such as diabetes. These microbiomes derived drugs help the physician in better diagnosis of the illness.Rising cases of chr…